CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 547137-547448
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T13195","span":{"begin":0,"end":311},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"1.Santilli J, Nathan R, Glassheim J .Patient receiving immunotherapy report it is effective as assesses by rhinitis outcomes questionnaire(RAQ) in private (42)) is a protein involved in the parasite invasion of host erythrocytes and is a leading vaccine candidate for the erythrocyte stage of malaria infection."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T90","span":{"begin":0,"end":311},"obj":"Sentence"}],"text":"1.Santilli J, Nathan R, Glassheim J .Patient receiving immunotherapy report it is effective as assesses by rhinitis outcomes questionnaire(RAQ) in private (42)) is a protein involved in the parasite invasion of host erythrocytes and is a leading vaccine candidate for the erythrocyte stage of malaria infection."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5219","span":{"begin":107,"end":115},"obj":"Disease"},{"id":"T5220","span":{"begin":293,"end":300},"obj":"Disease"},{"id":"T5221","span":{"begin":301,"end":310},"obj":"Disease"}],"attributes":[{"id":"A5219","pred":"mondo_id","subj":"T5219","obj":"http://purl.obolibrary.org/obo/MONDO_0003014"},{"id":"A5220","pred":"mondo_id","subj":"T5220","obj":"http://purl.obolibrary.org/obo/MONDO_0005136"},{"id":"A5221","pred":"mondo_id","subj":"T5221","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"1.Santilli J, Nathan R, Glassheim J .Patient receiving immunotherapy report it is effective as assesses by rhinitis outcomes questionnaire(RAQ) in private (42)) is a protein involved in the parasite invasion of host erythrocytes and is a leading vaccine candidate for the erythrocyte stage of malaria infection."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T2855","span":{"begin":107,"end":115},"obj":"Phenotype"}],"attributes":[{"id":"A2855","pred":"hp_id","subj":"T2855","obj":"http://purl.obolibrary.org/obo/HP_0012384"}],"text":"1.Santilli J, Nathan R, Glassheim J .Patient receiving immunotherapy report it is effective as assesses by rhinitis outcomes questionnaire(RAQ) in private (42)) is a protein involved in the parasite invasion of host erythrocytes and is a leading vaccine candidate for the erythrocyte stage of malaria infection."}